1. Home
  2. RNGR vs MNPR Comparison

RNGR vs MNPR Comparison

Compare RNGR & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ranger Energy Services Inc.

RNGR

Ranger Energy Services Inc.

HOLD

Current Price

$16.28

Market Cap

403.7M

Sector

Energy

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$62.74

Market Cap

368.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNGR
MNPR
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
403.7M
368.9M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
RNGR
MNPR
Price
$16.28
$62.74
Analyst Decision
Buy
Strong Buy
Analyst Count
1
11
Target Price
$20.00
$107.00
AVG Volume (30 Days)
282.0K
164.9K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
6.81%
N/A
EPS Growth
N/A
54.99
EPS
0.12
N/A
Revenue
N/A
N/A
Revenue This Year
$23.86
N/A
Revenue Next Year
$4.37
N/A
P/E Ratio
$136.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.56
$28.40
52 Week High
$18.82
$105.00

Technical Indicators

Market Signals
Indicator
RNGR
MNPR
Relative Strength Index (RSI) 42.33 56.98
Support Level $15.62 $51.71
Resistance Level $17.94 $67.90
Average True Range (ATR) 0.52 5.65
MACD -0.01 0.27
Stochastic Oscillator 36.80 68.24

Price Performance

Historical Comparison
RNGR
MNPR

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc offers high specification mobile rig well services, cased hole wireline services, and ancillary services in the U.S. oil and gas industry. Its services facilitate operations throughout the lifecycle of a well, including the completion, production, maintenance, intervention, workover, and abandonment phases. The company's reportable segments are: High Specification Rigs, Wireline Services, Processing Solutions and Ancillary Services. Maximum revenue is generated from the High Specification Rigs segment, which offers high specification well service rigs and complementary equipment and services to facilitate operations throughout the lifecycle of a well. The high specification rig services consist of well completion support, workovers, and well maintenance services.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: